This federal contract award is for the delivery of 8 mg Ondansetron HCL tablets to the Defense Logistics Agency (DLA), a defense agency. The $12,618.04 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, on December 5, 2024, with a completion date of December 6, 2024. The contract does not have a set-aside designation, indicating open competition.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order appears to be part of that broader IDC, enabling efficient government procurement of essential pharmaceutical products for military personnel, veterans, and other federal beneficiaries.
Generated 3/6/25, 9:57 AM